Latest research shows how cancer cells react to chemotherapy


EU-funded researchers have made good progress in understanding how cancer cells can sometimes resist the effects of chemotherapy. This new knowledge will move forward the development of increasingly effective cancer treatments and could go some way to reducing relapse, good news for cancer patients and scientists alike. 

As part of the APO-SYS ('Apoptosis systems biology applied to cancer and AIDS') project, which received a funding boost of EUR 11 million under the 'Health' Theme of the Seventh Framework Programme (FP7), the team of researchers from the Dublin-based Royal College of Surgeons in Ireland (RCSI) carried out a comprehensive study of cancer cells. 


More information

ECRAAL - European Centre for Research in Asia, Africa and Latin America
Rond Point Schuman 6, 1040 Brussels - Scotland House
Tel: +32 2 282 84 16